Westmount Partners, LLC

Position in PFE — Pfizer Inc

CIK 2051491 LOS ANGELES, CA

Position in PFE

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$255,103

-$98,648 QoQ

Shares Held

10,594

-15.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#2,252

of 2,821 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Westmount Partners, LLC holds $10,104,775 across 9 Drug Manufacturers - General names. PFE ranks #8 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,289	$2,745,495
2	JNJ	Johnson & Johnson	9,734	$2,472,143
3	ABBV	AbbVie Inc.	5,727	$1,441,142
4	AMGN	Amgen Inc	3,735	$1,352,518
5	MRK	Merck & Co., Inc.	5,013	$644,170
6	BMY	Bristol Myers Squibb Co	10,185	$586,859
7	GILD	Gilead Sciences, Inc.	2,887	$364,743
8	PFE	Pfizer Inc This page	10,594	$255,103

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$255,103	10,594	-15.9%	Shares	Sole	2026-07-07
2026-03-31	$353,751	12,598	+21.1%	Shares	Sole	2026-04-16
2025-12-31	$259,009	10,402	+17.9%	Shares	Sole	2026-01-15
2025-09-30	$224,886	8,826	-36.9%	Shares	Sole	2025-10-14
2025-06-30	$339,141	13,991	-6.1%	Shares	Sole	2025-07-09
2025-03-31	$377,515	14,898	+0.0%	Shares	Sole	2025-05-01
2024-12-31	$395,058	14,891	-9.9%	Shares	Sole	2025-01-13
2024-09-30	$478,493	16,534	-4.2%	Shares	Sole	2025-01-13
2024-06-30	$482,990	17,262	-7.1%	Shares	Sole	2025-01-28
2024-03-31	$515,456	18,575	+9.8%	Shares	Sole	2025-01-28
2023-12-31	$487,040	16,917	-8.6%	Shares	Sole	2025-01-28
2023-09-30	$613,744	18,503	-4.1%	Shares	Sole	2025-01-28
2023-06-30	$707,997	19,302	+0.2%	Shares	Sole	2025-01-28
2023-03-31	$785,644	19,256	-6.1%	Shares	Sole	2025-01-29
2022-12-31	$1,050,727	20,506	—	Shares	Sole	2025-01-28
No filing history on record for this holder in this stock.